RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Morris Benveniste to Mutation

This is a "connection" page, showing publications Morris Benveniste has written about Mutation.
Connection Strength

0.207
  1. Weeks AM, Harms JE, Partin KM, Benveniste M. Functional insight into development of positive allosteric modulators of AMPA receptors. Neuropharmacology. 2014 Oct; 85:57-66.
    View in: PubMed
    Score: 0.089
  2. Inagaki A, Frank CA, Usachev YM, Benveniste M, Lee A. Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca?? channel due to a familial hemiplegic migraine mutation. Neuron. 2014 Jan 08; 81(1):91-102.
    View in: PubMed
    Score: 0.087
  3. Karbat I, Ilan N, Zhang JZ, Cohen L, Kahn R, Benveniste M, Scheuer T, Catterall WA, Gordon D, Gurevitz M. Partial agonist and antagonist activities of a mutant scorpion beta-toxin on sodium channels. J Biol Chem. 2010 Oct 01; 285(40):30531-8.
    View in: PubMed
    Score: 0.017
  4. Cohen L, Troub Y, Turkov M, Gilles N, Ilan N, Benveniste M, Gordon D, Gurevitz M. Mammalian skeletal muscle voltage-gated sodium channels are affected by scorpion depressant "insect-selective" toxins when preconditioned. Mol Pharmacol. 2007 Nov; 72(5):1220-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support